Biologic CMO Oso BioPharmaceuticals Manufacturing is a contract manufacturing organization specializing in biologics and pharmaceutical injectables with capabilities for low-volume and potent compounds, presenting a reliable partner for niche biologic program manufacturing and scale-up.

Quality & Expertise The company emphasizes high quality assurance, seasoned industry professionals, and clear communication, suggesting opportunities to position service enhancements, audits, and GMP-compliant processes as differentiators in complex biologic projects.

Strategic Partnerships As a division of AMRI with a regional footprint in Albuquerque, there is potential to leverage AMRI’s broader capabilities for integrated development and manufacturing workflows, enabling end-to-end solutions for clients seeking turnkey biologic production.

Financial Capacity With reported revenue in the several hundred million range, OsoBio has financial scale to support multi-phase programs, capital investments, and risk-sharing manufacturing agreements for long-term client engagements.

Market Positioning Targeting niche, high-complexity injectables and potent compounds, OsoBio presents opportunities to win CDMO projects requiring specialized handling, tight quality control, and rapid responsiveness in a competitive landscape.